Challenges with judging and interpreting a drug's launch price
- PMID: 40705728
- DOI: 10.37765/ajmc.2025.89715
Challenges with judging and interpreting a drug's launch price
Abstract
This commentary explains why comparing a launch price with a value-based price from a cost-effectiveness analysis requires further examination.
MeSH terms
LinkOut - more resources
Full Text Sources